Home ›
Prostate Cancer Trials ›
NCT07635238
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.
Trial Details
NCT ID NCT07635238
Phase PHASE2
Sponsor Memorial Sloan Kettering Cancer Center
Status RECRUITING
Cancer Type Prostate Cancer
Interventions MR-guided Stereotactic Body Radiation Therapy
Locations (sample) Basking Ridge, New Jersey, United States|40.70621,-74.54932 Middletown, New Jersey, United States|40.39428,-74.11709 Montvale, New Jersey, United States|41.04676,-74.02292 Commack, New York, United States|40.84288,-73.29289 Harrison, New York, United States|40.96899,-73.71263
Key Eligibility Criteria
Documentation of Disease o Patients must have pathologically confirmed prostate adenocarcinoma. Definition of Disease Grade Group (GG) 1, 2, or 3.
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Prostate Cancer Trials on Trialify →